New drug KESONOTIDE™ enters human trials for multiple cancers
NCT ID NCT06926075
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug, KESONOTIDE™, in people with advanced solid tumors like prostate, breast, lung, ovarian, brain, pancreas, or skin cancer. The trial has two phases: first, finding the safest dose, then testing that dose in a larger group. About 80 participants will be enrolled to check safety and how the drug behaves in the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
KESONOTIDE™ (a vimentin inhibitor)
What this could lead to
If it works, this could point toward a new treatment option for several advanced solid cancers.
What could go wrong
This is an early phase trial with only 80 participants, so the drug may not prove effective or safe enough for wider use. Side effects are unknown at this stage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
South Western Sydney Local Health District
RECRUITINGLiverpool, New South Wales, 2170, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Southside Cancer Centre
RECRUITINGMiranda, New South Wales, 2228, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
St George Private Hospital
RECRUITINGKogarah, New South Wales, 2217, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••